$3.15
-0.10-3.08%
At close: -
$3.13
-0.02-0.63%
After Hours: 7:34 PM EDT
Comments
Loading...
Citius Pharmaceuticals (CTXR) Forecast
NewsEarningsCitius Pharmaceuticals (CTXR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCitius Pharmaceuticals (NASDAQ:CTXR) Stock Quotes, Forecast and News Summary
Citius Pharmaceuticals Stock (NASDAQ: CTXR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Citius Pharmaceuticals (CTXR) stock?
You can purchase shares of Citius Pharmaceuticals (NASDAQ:CTXR) through any online brokerage.
Who are Citius Pharmaceuticals (CTXR) competitors?
Other companies in Citius Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and SCYNEXIS (NASDAQ:SCYX).
What is the forecast, or price target, for Citius Pharmaceuticals (CTXR) stock?
Citius Pharmaceuticals has a consensus price target of $6.33.
What is the current price for Citius Pharmaceuticals (CTXR)?
The stock price for Citius Pharmaceuticals (NASDAQ: CTXR) is $3.1301 last updated January 22, 2025 at 7:34 PM EST.
Does Citius Pharmaceuticals (CTXR) pay a dividend?
There are no upcoming dividends for Citius Pharmaceuticals.
When is Citius Pharmaceuticals (NASDAQ:CTXR) reporting earnings?
Citius Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, February 12, 2025.
Is Citius Pharmaceuticals (CTXR) going to split?
There is no upcoming split for Citius Pharmaceuticals.
What sector and industry does Citius Pharmaceuticals (CTXR) operate in?
Citius Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.